Navigation Links
Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
Date:9/26/2007

Presentations to illustrate wide applicability of JuvImmune and JuvaVax

product platforms

PLEASANTON, Calif., Sept. 26 /PRNewswire/ -- Juvaris BioTherapeutics, Inc. announced today six scientific presentations at the upcoming IDSA meeting on October 6, 2007. The data will cover the consistency in multiple species of JuvImmune immunostimulant and JuvaVax products being developed for HIV, influenza, hepatitis and HSV-2.

"We are pleased that the company and its collaborators are presenting a number of high quality papers at the IDSA meeting in San Diego," said Martin D. Cleary, Co-founder, Chairman and CEO of Juvaris. "We believe these presentations demonstrate the wide applicability of the Juvaris JuvImmune and JuvaVax vaccine platforms for prophylaxis and treatment of infectious disease."

About Juvaris

Juvaris BioTherapeutics was created in 2003 to develop an immunotherapeutic product platform for the treatment of infectious diseases and cancers using lipid-DNA complexes. Cationic lipids are formulated with non-coding DNA (plasmid) to create the JuvImmune Immunostimulant, a lipid-DNA complex, which as a single product will have utility in multiple infectious disease and cancer applications. The JuvImmune product has been shown to be at least 50-times more potent at triggering innate immune activation and interferon release than current immune stimulants.

When combined with disease-specific antigens, the technology creates JuvaVax vaccines capable of activating substantial antibody- and cell-mediated immune responses, particularly induction of cytotoxic T lymphocytes (CTL). Immunological responses elicited by the lipid-DNA complexes have been successfully demonstrated in both prophylactic and therapeutic settings in a variety of mammals including rodents, rabbits, cats, dogs and non-human primates. This platform provides the opportunity to develop many disease-specific immunotherapy products, for which
'/>"/>

SOURCE Juvaris BioTherapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , COLUMBUS, Ohio, Nov. 30 The...or one of the nation,s first minority business ear...n Cleveland December 3, is called "Transforming th...iness Early-Stage Capital Summit." It will feature...nority business leaders and local minority entrepr...
(Date:11/30/2009)... , NEW YORK, Nov. 30 /PRNewswire-USNewswire/ -...search (MJFF) today announced $1.5 million in tota...potentially disease-modifying therapies for Parkin...Novel Approaches to Drug Discovery for Parkinson,s...lan Corporation, plc (NYSE: ELN ), a neuroscienc...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Dr. Jessica ...ge Washington University Medical Center in Washing... Breast-Specific Gamma Imaging (BSGI) in clinical ...agnosis of breast cancer today at the annual meeti...SNA). ,, "The purpose of the exhibit was to dem...
(Date:11/30/2009)... PDS, a leader in providing sma...nity, announces Pajama Pathology®, evolutioniz... same ‘gold standard’ software used by...orld, but on a ‘cost per slide’ basis....RWEB) November 30, 2009 -- PDS has announced anoth...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
...biometrics company enabling applications for the r...iance with Methode Electronics, Inc. One of the ma...a solid Tier 1 automotive supplier focusing on tec...ubsystem devices. Together, Methode and Lumidigm w...markets, including transportation. The partnership...
...ancing/strategic alte... Inc.,(OTC Bulletin Board: ABOS) announced today t...ons exclusively on obtaining financing or consumma... the Company,s remaining cash,resources, the Compa...pt,for Shawn Cain, the Company,s President and CEO...
...to Curb Unsafe Sex and Drug, Use are Highly Effe...e, MEXICO CITY, Aug. 5 In a new report released ...s on global leaders to aggressively,expand HIV pre...iors,including unsafe sex and drug use. Citing hun..., the report concludes that behavior-change progra...
Other Biology Technology: Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development 2Arbios Announces It Has Suspended Operations 2Arbios Announces It Has Suspended Operations 3Arbios Announces It Has Suspended Operations 4Arbios Announces It Has Suspended Operations 5Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 2Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 3Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV 4
(Date:11/26/2009)...in eight European countries has shown that closing...demic could have a significant role in reducing il...n access journal BMC Infectious Diseases compare...eekends/holidays, finding that they were reduced w...and Antwerp University, Belgium, led a team of Eur...
(Date:11/25/2009)...oduced in the stomach, may be used to boost resist...isease, Yale School of Medicine researchers report...urnal of Neuroscience . , Parkinson,s disease is...n area of the midbrain known as the substantia nig... Reduced production of dopamine in late-stage Park...
(Date:11/25/2009)...lifetime, the heart pumps some 250 million liters ..., the muscle fibers of the heart have to be extrem...gang Rottbauer, vice chair of the Department of Me...rman: Prof. Dr. H. A. Katus), has discovered a pro...smallest muscular unit, the sarcomere. In cooperat...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2New AOTMP Research Reveals that 21 25 of Enterprises Don 26apos 3Bt Have or Don 26apos 3Bt Know if they Have Telecom Expense Management Reporting 56717 1New AOTMP Research Reveals that 21 25 of Enterprises Don 26apos 3Bt Have or Don 26apos 3Bt Know if they Have Telecom Expense Management Reporting 56717 2SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 1SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 2SourceMedical Driving ASC Electronic Health Record Adoption through Compliance Guarantee and Financing Program 56714 3California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 1California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 2California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 3California Surrogacy and Egg Donation Professionals Team Up Free Egg Donation Cycle 56711 4
... Where have all the bridle shiner gone" Thats the ...tists are trying to answer, and the outcome will s... Delaware River., Bridle shinernot easy to spot at...e mid-Atlantic region, including small streams in ...s prompted Pennsylvania to classify the fish as en...
...12, 2007 Visually unsettling and intellectually p...going series of conceptual still lifes. Chervinsk...ics, chemistry and materials science, will lecture... at the University of Houston at 7 p.m., Thursday,...The event is free and open to the public. , We ...
...cal Society of America (ESA) is pleased to announc...rds will be presented at the 2007 Annual Meeting i...s will be presented on December 11. The Societys p...th professional awards listed first. , Professi...n Extension This award recognizes outstanding cont...
Other Biology News:Tiny fish can yield big clues to Delaware River health 2Art meets science: Engineer discusses his photographs in free UH lecture 2 Entomological Society announces 2007 award winners 2 Entomological Society announces 2007 award winners 3 Entomological Society announces 2007 award winners 4 Entomological Society announces 2007 award winners 5 Entomological Society announces 2007 award winners 6 Entomological Society announces 2007 award winners 7 Entomological Society announces 2007 award winners 8
Eppendorf tube holder, for Tube rack 175 x 12 mm from GE Healthcare, formerly Amersham Biosciences
Sheep Serum from CHEMICON
Agarose, pulse field from GE Healthcare, formerly Amersham Biosciences
ELISA Plate Sealers, 100 Pack from R&D Systems
Biology Products: